Taiko Pharmaceutical: Summary of Financial Results for the third quarter 2024
Taiko Pharmaceutical: Consolidated financial results report for the 3rd quarter of the fiscal year ending 2024/12 (FY2024)
Taiko Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)
Taiko Pharmaceutical: Announcement: The transcript article of the Q2 (interim) earnings conference for the fiscal year ending December 2024 has been published on LogMe Finance.
Taiko Pharmaceutical: Consolidated financial statements for the second quarter (interim period) of the fiscal year ending December 2024 (FY2024).
Taiko Pharmaceutical: Confirmatory letter.
Taiko Pharmaceutical: Interim Report - 79th period (January 1, 2024 - December 31, 2024)
Taiko Pharmaceutical: Summary of the Q2 2024 financial statements.
Taiko Pharmaceutical: Announcements of individual stocks regarding the revision of consolidated performance estimates and the restructuring of production system in pharmaceutical business (recognition of impairment losses).
Taiko Pharmaceutical: 2024 December Q2 (Interim) Financial Results (Japan Standard) (Consolidated)
Taiko Pharmaceutical: Confirmation letter
Taiko Pharmaceutical: Quarterly Report - 79th Quarter 1 (2024/01/01 to 2024/03/31)
Taiko Pharmaceutical: Summary of financial results for the 1st quarter of 2024
Taiko Pharmaceutical: Consolidated financial results report for the 1st quarter of the fiscal year ending 2024/12 (FY2024)
Taiko Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)
Taiko Pharmaceutical: Notice regarding completion of payment of disposal of treasury stock as stock reward with transfer restrictions
Taiko Pharmaceutical: Corporate Governance Report 2024/04/12
Taiko Pharmaceutical: Extraordinary Report
Taiko Pharmaceutical: Notice regarding disposal of treasury stock as share compensation with transfer restrictions
Taiko Pharmaceutical: Internal Control Report - 78th Term (2023/01/01 - 2023/12/31)
No Data